More than 5,000 people have reported issues with metal-on-metal hip implants to the Food and Drug Administration since January, according to a report in the New York Times.
In the past eight months, the FDA has received more complaints about the devices than in the last four years combined. The complaints stem from failed procedures using the metal-on-metal devices, which have lasted only a few years as opposed to the standard 15 years or more, according to the report. Johnson & Johnson's DePuy ASR hip replacement system, which was recalled last year, accounts for approximately 75 percent of these complaints. In total, the FDA has received about 7,500 complaints on the ASR hip implants.
At the moment, metal device use has decreased to about 5 percent of the market, even though some systems perform well with appropriate patients, according to the report. The FDA has asked for additional studies regarding metal-on-metal implants, and companies including DePuy, Zimmer and Wright Medical have submitted proposals for additional research.
Related Articles on Hip Implants:
WSJ: Johnson & Johnson Hip Implants Set Off Pricey Mass Litigation
FDA Orders Additional Studies From Device Companies on Hip Implants
5 Reasons Why Controversy Surrounds Metal-on-Metal Hip Replacements
At the moment, metal device use has decreased to about 5 percent of the market, even though some systems perform well with appropriate patients, according to the report. The FDA has asked for additional studies regarding metal-on-metal implants, and companies including DePuy, Zimmer and Wright Medical have submitted proposals for additional research.
Related Articles on Hip Implants:
WSJ: Johnson & Johnson Hip Implants Set Off Pricey Mass Litigation
FDA Orders Additional Studies From Device Companies on Hip Implants
5 Reasons Why Controversy Surrounds Metal-on-Metal Hip Replacements